These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 23400047)

  • 1. The current situation of treatment systems for alcoholism in Korea.
    Kim JW; Lee BC; Kang TC; Choi IG
    J Korean Med Sci; 2013 Feb; 28(2):181-9. PubMed ID: 23400047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Depression in alcohol addicted patients].
    Ponizovskiy PA; Gofman AG
    Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(7):146-150. PubMed ID: 26356528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New pharmacotherapies for alcohol dependence.
    Graham R; Wodak AD; Whelan G
    Med J Aust; 2002 Jul; 177(2):103-7. PubMed ID: 12098353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The BRENDA model: integrating psychosocial treatment and pharmacotherapy for the treatment of alcohol use disorders.
    Starosta AN; Leeman RF; Volpicelli JR
    J Psychiatr Pract; 2006 Mar; 12(2):80-9. PubMed ID: 16728904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Searching for responders to acamprosate and naltrexone in alcoholism treatment: rationale and design of the PREDICT study.
    Mann K; Kiefer F; Smolka M; Gann H; Wellek S; Heinz A;
    Alcohol Clin Exp Res; 2009 Apr; 33(4):674-83. PubMed ID: 19170666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined acamprosate and naltrexone, with cognitive behavioural therapy is superior to either medication alone for alcohol abstinence: a single centres' experience with pharmacotherapy.
    Feeney GF; Connor JP; Young RM; Tucker J; McPherson A
    Alcohol Alcohol; 2006; 41(3):321-7. PubMed ID: 16467406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does psychosocial treatment enhance the efficacy of acamprosate in patients with alcohol problems?
    De Wildt WA; Schippers GM; Van Den Brink W; Potgieter AS; Deckers F; Bets D
    Alcohol Alcohol; 2002; 37(4):375-82. PubMed ID: 12107041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances in the pharmacotherapy of alcoholism.
    Myrick H; Anton R
    Curr Psychiatry Rep; 2004 Oct; 6(5):332-8. PubMed ID: 15355755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combining treatments for alcoholism: why and how?
    Mattson ME; Litten RZ
    J Stud Alcohol Suppl; 2005 Jul; (15):8-16; discussion 6-7. PubMed ID: 16223051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of healthcare utilization among patients treated with alcoholism medications.
    Mark TL; Montejano LB; Kranzler HR; Chalk M; Gastfriend DR
    Am J Manag Care; 2010; 16(12):879-88. PubMed ID: 21348558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A literature review of cost-benefit analyses for the treatment of alcohol dependence.
    Popova S; Mohapatra S; Patra J; Duhig A; Rehm J
    Int J Environ Res Public Health; 2011 Aug; 8(8):3351-64. PubMed ID: 21909311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rationale for combining acamprosate and naltrexone for treating alcohol dependence.
    Mason BJ
    J Stud Alcohol Suppl; 2005 Jul; (15):148-56; discussion 140. PubMed ID: 16223066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of acamprosate and different kinds of psychosocial support in relapse prevention of alcoholism. Results from a non-blind, multicentre study.
    Soyka M; Preuss U; Schuetz C
    Drugs R D; 2002; 3(1):1-12. PubMed ID: 11881521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Meta-analysis of pharmacological therapy with acamprosate, naltrexone, and disulfiram--a systematic review].
    Petrov I; Krogh J; Nordentoft M
    Ugeskr Laeger; 2011 Nov; 173(48):3103-9. PubMed ID: 22118653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alcohol dependence: after the withdrawal phase. Long-term abstinence: better health and psychosocial status. Psychosocial support for a chronic disorder. Some drugs are useful adjuncts to medical support.
    Prescrire Int; 2009 Oct; 18(103):222-3. PubMed ID: 19882797
    [No Abstract]   [Full Text] [Related]  

  • 16. Combined therapy: what does acamprosate and naltrexone combination tell us?
    Kiefer F; Wiedemann K
    Alcohol Alcohol; 2004; 39(6):542-7. PubMed ID: 15456690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acamprosate for the treatment of alcohol dependence.
    Boothby LA; Doering PL
    Clin Ther; 2005 Jun; 27(6):695-714. PubMed ID: 16117977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Long-term treatment of alcohol dependance].
    Fideli LP; Lejoyeux M
    Gastroenterol Clin Biol; 2002 May; 26(5 Suppl):B169-73. PubMed ID: 12068285
    [No Abstract]   [Full Text] [Related]  

  • 19. How cognitive assessment through clinical neurophysiology may help optimize chronic alcoholism treatment.
    Campanella S; Petit G; Verbanck P; Kornreich C; Noel X
    Neurophysiol Clin; 2011 Jul; 41(3):115-23. PubMed ID: 21784323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acamprosate and naltrexone treatment for alcohol dependence: an evidence-based risk-benefits assessment.
    Mason BJ
    Eur Neuropsychopharmacol; 2003 Dec; 13(6):469-75. PubMed ID: 14636963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.